Literature DB >> 20865348

Design and implementation of high throughput screening assays.

Ricardo Macarrón1, Robert P Hertzberg.   

Abstract

High throughput screening (HTS) is at the core of the drug discovery process, and so it is critical to design and implement HTS assays in a comprehensive fashion involving scientists from the disciplines of biology, chemistry, engineering, and informatics. This requires careful analysis of many variables, starting with the choice of assay target and ending with the discovery of lead compounds. At every step in this process, there are decisions to be made that can greatly impact the outcome of the HTS effort, to the point of making it a success or a failure. Although specific guidelines should be established to insure that the screening assay reaches an acceptable level of quality, many choices require pragmatism and the ability to compromise opposing forces.

Mesh:

Year:  2011        PMID: 20865348     DOI: 10.1007/s12033-010-9335-9

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  29 in total

1.  Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic.

Authors:  W H Miller; D P Alberts; P K Bhatnagar; W E Bondinell; J F Callahan; R R Calvo; R D Cousins; K F Erhard; D A Heerding; R M Keenan; C Kwon; P J Manley; K A Newlander; S T Ross; J M Samanen; I N Uzinskas; J W Venslavsky; C C Yuan; R C Haltiwanger; M Gowen; S M Hwang; I E James; M W Lark; D J Rieman; G B Stroup; L M Azzarano; K L Salyers; B R Smith; K W Ward; K O Johanson; W F Huffman
Journal:  J Med Chem       Date:  2000-01-13       Impact factor: 7.446

2.  A homogeneous fluorescence polarization assay adaptable for a range of protein serine/threonine and tyrosine kinases.

Authors:  Elizabeth A Gaudet; Kuo-Sen Huang; Yan Zhang; Wei Huang; David Mark; J Richard Sportsman
Journal:  J Biomol Screen       Date:  2003-04

Review 3.  Screening in a spirit haunted world.

Authors:  Brian K Shoichet
Journal:  Drug Discov Today       Date:  2006-07       Impact factor: 7.851

Review 4.  Critical review of the role of HTS in drug discovery.

Authors:  Ricardo Macarron
Journal:  Drug Discov Today       Date:  2006-04       Impact factor: 7.851

5.  A luminescent oxygen channeling immunoassay for the determination of insulin in human plasma.

Authors:  Fritz Poulsen; Kirsten Borres Jensen
Journal:  J Biomol Screen       Date:  2007-01-26

6.  A comparison of assay performance measures in screening assays: signal window, Z' factor, and assay variability ratio.

Authors:  Philip W Iversen; Brian J Eastwood; G Sitta Sittampalam; Karen L Cox
Journal:  J Biomol Screen       Date:  2006-02-20

Review 7.  Application of scintillation proximity assay in drug discovery.

Authors:  Shaogui Wu; Bailing Liu
Journal:  BioDrugs       Date:  2005       Impact factor: 5.807

8.  Statistics and decision making in high-throughput screening.

Authors:  Isabel Coma; Jesus Herranz; Julio Martin
Journal:  Methods Mol Biol       Date:  2009

Review 9.  Screening and characterization of enzyme inhibitors as drug candidates.

Authors:  K Bush
Journal:  Drug Metab Rev       Date:  1983       Impact factor: 4.518

10.  High throughput screening technologies for direct cyclic AMP measurement.

Authors:  Daniela Gabriel; Magali Vernier; Martin J Pfeifer; Boris Dasen; Laurent Tenaillon; Rochdi Bouhelal
Journal:  Assay Drug Dev Technol       Date:  2003-04       Impact factor: 1.738

View more
  23 in total

Review 1.  High-throughput screening strategies for targeted identification of therapeutic compounds in colorectal cancer.

Authors:  Agnieszka B Bialkowska; Vincent W Yang
Journal:  Future Oncol       Date:  2012-03       Impact factor: 3.404

2.  Using C. elegans for antimicrobial drug discovery.

Authors:  Athanasios Desalermos; Maged Muhammed; Justin Glavis-Bloom; Eleftherios Mylonakis
Journal:  Expert Opin Drug Discov       Date:  2011-06-01       Impact factor: 6.098

3.  Large scale structural rearrangement of a serine hydrolase from Francisella tularensis facilitates catalysis.

Authors:  Ekaterina V Filippova; Leigh A Weston; Misty L Kuhn; Brett Geissler; Alexandra M Gehring; Nicola Armoush; Chinessa T Adkins; George Minasov; Ievgeniia Dubrovska; Ludmilla Shuvalova; James R Winsor; Luke D Lavis; Karla J F Satchell; Daniel P Becker; Wayne F Anderson; R Jeremy Johnson
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

4.  Fluorogenic structure activity library pinpoints molecular variations in substrate specificity of structurally homologous esterases.

Authors:  Alex White; Andrew Koelper; Arielle Russell; Erik M Larsen; Charles Kim; Luke D Lavis; Geoffrey C Hoops; R Jeremy Johnson
Journal:  J Biol Chem       Date:  2018-07-13       Impact factor: 5.157

5.  A small molecule inhibitor of Pot1 binding to telomeric DNA.

Authors:  Sarah E Altschuler; Johnny E Croy; Deborah S Wuttke
Journal:  Biochemistry       Date:  2012-09-26       Impact factor: 3.162

6.  High-throughput screening for RecA inhibitors using a transcreener adenosine 5'-O-diphosphate assay.

Authors:  Eliza J R Peterson; William P Janzen; Dmitri Kireev; Scott F Singleton
Journal:  Assay Drug Dev Technol       Date:  2011-12-22       Impact factor: 1.738

7.  A high-throughput fluorescence polarization anisotropy assay for the 70N domain of replication protein A.

Authors:  Elaine M Souza-Fagundes; Andreas O Frank; Michael D Feldkamp; Daniel C Dorset; Walter J Chazin; Olivia W Rossanese; Edward T Olejniczak; Stephen W Fesik
Journal:  Anal Biochem       Date:  2011-12-01       Impact factor: 3.365

8.  Development of a Novel Screening Strategy Designed to Discover a New Class of HIV Drugs.

Authors:  Nancy Cheng; Sook-Kyung Lee; P Scott Donover; Mel Reichman; Celia A Schiffer; Emily A Hull-Ryde; Ronald Swanstrom; William P Janzen
Journal:  J Lab Autom       Date:  2013-12-04

9.  Ligands for glaucoma-associated myocilin discovered by a generic binding assay.

Authors:  Susan D Orwig; Pamela V Chi; Yuhong Du; Shannon E Hill; Marchello A Cavitt; Amrithaa Suntharalingam; Katherine C Turnage; Chad A Dickey; Stefan France; Haian Fu; Raquel L Lieberman
Journal:  ACS Chem Biol       Date:  2013-12-09       Impact factor: 5.100

10.  Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease.

Authors:  Jennifer C Milligan; Theresa U Zeisner; George Papageorgiou; Dhira Joshi; Christelle Soudy; Rachel Ulferts; Mary Wu; Chew Theng Lim; Kang Wei Tan; Florian Weissmann; Berta Canal; Ryo Fujisawa; Tom Deegan; Hema Nagaraj; Ganka Bineva-Todd; Clovis Basier; Joseph F Curran; Michael Howell; Rupert Beale; Karim Labib; Nicola O'Reilly; John F X Diffley
Journal:  Biochem J       Date:  2021-07-16       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.